Product
ARD-101
3 clinical trials
4 indications
Indication
ObesityIndication
Weight Loss SurgeryIndication
Weight GainIndication
Prader-Willi SyndromeClinical trial
A Phase 2, Placebo-Controlled, Randomized, Blinded Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of ARD-101 in Adults With ObesityStatus: Completed, Estimated PCD: 2022-11-09
Clinical trial
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, and Efficacy of ARD-101 in Subjects At Least One Year After Bariatric SurgeryStatus: Completed, Estimated PCD: 2023-02-03
Clinical trial
A Phase 2, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of ARD-101 in Patients With Prader-Willi SyndromeStatus: Recruiting, Estimated PCD: 2024-01-01